Longterm Incentive Plans (Tables)

12 Months Ended

Jan. 31, 2022

Schedule of continuity of the Company's RSUs

	Number of RSUs
Outstanding, January 31, 2019		–
Granted		275,000
Outstanding, January 31, 2020		275,000
Granted		30,000
Common shares issued on vesting (Notes 12(i) and 18)		(271,667	)
Forfeited (Note 18)		(8,333	)
Outstanding, January 31, 2021		25,000
Common shares issued on vesting (Note 12(a))		(15,000	)
Outstanding, January 31, 2022		10,000

Schedule of continuity of the Company's performance stock units (PSUs)

	Number of PSUs
Outstanding, January 31, 2019		–
Granted		75,000
Outstanding, January 31, 2020		75,000
Common shares issued on vesting (Notes 12(i) and 18)		(25,000	)
Expired (Note 18)		(25,000	)
Outstanding, January 31, 2022 and 2021		25,000

Schedule of continuity of the Company's share purchase options

	Number of Options			Weighted Average Exercise Price			Weighted Average Remaining Contractual Life (years)
Outstanding, January 31, 2019		1,369,183			4.60			3.26
Granted		807,500			3.19			4.38
Forfeited/cancelled		(704,183	)		(5.01	)		–
Outstanding, January 31, 2020		1,472,500			3.82			3.08
Granted (Note 18)		1,430,000			1.03			3.01
Granted pursuant to acquisition (Note 6(b))		856,880			3.05			0.35
Forfeited (Note 18)		(836,668	)		(2.68	)		–
Outstanding, January 31, 2021		2,922,712			2.56			2.19
Granted (Note 18)		1,270,000			0.48			2.41
Forfeited (Note 18)		(1,782,712	)		(3.51	)		–
Outstanding, January 31, 2022		2,410,000			0.76			1.98

Schedule of share purchase options

Options Outstanding		Options Exercisable		Exercise Price $		Expiry Date
	10,000		5,000		0.27	December 31, 2022
	40,000		20,000		1.80	January 4, 2023
	10,000		10,000		2.50	January 20, 2023
	700,000		416,667		0.63	April 28, 2023
	20,000		20,000		0.275	September 27, 2023
	20,000		20,000		0.29	November 28, 2023
	840,000		840,000		0.77	December 8, 2023
	520,000		520,000		0.295	October 13, 2024
	180,000		122,500		1.80	May 5, 2025
	50,000		25,000		2.40	May 10, 2025
	20,000		10,000		1.80	May 21, 2025
	2,410,000		2,009,167

Summary of the continuity of MedMelior's share purchase options

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)
Outstanding, January 31, 2021 and August 31, 2020 (date of acquisition (Note 6(b))		–		–		–
Granted (Note 18)		1,100,000		0.10		3.00
Outstanding, January 31, 2022		1,100,000		0.10		2.91

Options Outstanding		Options Exercisable		Exercise Price $		Expiry Date
	1,100,000		275,000		0.10	December 28, 2024